TotalMarketCap

Takeda Pharmaceutical

TAKNYSE JapanHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$58.520 B

$18.52 +0.82%

Close of 9 Oct 2026

As of 9 Oct 2026, Takeda Pharmaceutical (TAK) has a market capitalization of $58.5B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #13GSKGSK$94.1B
  2. #14Regeneron PharmaceuticalsREGN$76.1B
  3. #15Takeda PharmaceuticalTAK$58.5B
  4. #16Teva Pharmaceutical IndustriesTEVA$45.7B
  5. #17BeOne MedicinesONC$39.8B

What if Takeda Pharmaceutical were worth as much as…

Open the what-if tool →

Gold $29.1T

$9,197.24

Per share 497× higher

Bitcoin $1.66T

$525.53

Per share 28.4× higher

Nvidia $5.55T

$1,757.86

Per share 94.9× higher

Or at a round number

$100.0B$200.0B$500.0B$1.00T

Where these numbers come from

Share counts and financials for Takeda Pharmaceutical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 10 Oct 2026. Read the methodology.